Impact Of The Gut Microbiota On Host Cells Energy Metabolism: Role In Health And In Inflammatory bowel disease
The ENERGISED project aims to explore how altered gut microbiota affects host cell energy metabolism in inflammatory bowel diseases to develop new microbiota-based therapies.
Projectdetails
Introduction
Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are immune-related disorders characterized by inappropriate gut inflammation. Their incidence has increased dramatically in Western countries in recent decades, supporting a role for environmental factors.
Current Challenges
Despite the development of new treatments, IBD are insufficiently controlled in a large proportion of patients, inducing an alteration in quality of life and a socioeconomic burden. A better understanding of the pathogenesis and identification of new therapeutic targets are therefore urgently needed.
Role of Gut Microbiota
In this context, the gut microbiota has been recognized as a strong actor in IBD. Additionally, an alteration in intestinal and immune cell energy metabolism has been suggested in the pathogenesis.
Host-Microbe Interactions
Classical host-microbe interaction concepts rely on:
- The recognition of conserved microbial motifs by innate immunity sensors
- The action of microbial molecules on a host cell receptor
However, energy metabolism plays a crucial role in mounting the appropriate cellular response, and emerging data indicate that the gut microbiota may directly affect it.
Hypothesis
I hypothesize that the altered gut microbiota in IBD contributes to the impairment of host cell energy metabolism and pathogenesis.
Aims of ENERGISED
The aims of ENERGISED are to:
- Identify the microorganisms and microbiota-derived metabolites impacting host cell energy metabolism and the mechanisms involved.
- Decipher the consequences of gut microbiota alterations on host cell energy metabolism in IBD.
- Design new microbiota-based therapeutic strategies to manipulate the host cell energy state in IBD.
Project Scope
This challenging project involves multidisciplinary aspects from microbiology to immunology, metabolism, and medicine; the use of multiple cutting-edge technologies; and translational analysis from mice to humans.
Societal Impact
In addition to its scientific importance, it will have societal impacts due to the identification of new therapeutic strategies.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.999.265 |
Totale projectbegroting | € 1.999.265 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-8-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- SORBONNE UNIVERSITEpenvoerder
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
- INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutritionThe InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Metabolic Gut Inflammation in Crohn's diseaseThis project aims to investigate how dietary polyunsaturated fatty acids trigger gut inflammation in Crohn's disease, establishing a link between diet and disease progression for potential therapeutic strategies. | ERC Starting... | € 1.493.875 | 2022 | Details |
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modellingThis project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions. | ERC Starting... | € 1.499.323 | 2024 | Details |
T cell regulation by fed state bacterial metabolitesThis project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health. | ERC Starting... | € 1.499.548 | 2024 | Details |
Deciphering host-gut microbiota spatio-functional plasticity in inflammationThis project aims to investigate the spatiofunctional plasticity of gut bacteria in Crohn's disease, exploring host-microbe interactions and their impact on inflammation using advanced microbiological and immunological methods. | ERC Starting... | € 1.997.500 | 2023 | Details |
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.
Metabolic Gut Inflammation in Crohn's disease
This project aims to investigate how dietary polyunsaturated fatty acids trigger gut inflammation in Crohn's disease, establishing a link between diet and disease progression for potential therapeutic strategies.
Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling
This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.
T cell regulation by fed state bacterial metabolites
This project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health.
Deciphering host-gut microbiota spatio-functional plasticity in inflammation
This project aims to investigate the spatiofunctional plasticity of gut bacteria in Crohn's disease, exploring host-microbe interactions and their impact on inflammation using advanced microbiological and immunological methods.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel FoodDiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions. | EIC Pathfinder | € 3.999.222 | 2024 | Details |
MicroBioDx: karakterisatie van microbioom-gastheer interactiesTenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren. | Mkb-innovati... | € 143.080 | 2021 | Details |
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sourcesFIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS. | EIC Pathfinder | € 3.449.447 | 2024 | Details |
Linking Intestinal Bacteria and Host Metabolism to Tackle Type 2 Diabetes with Novel Food
DiBaN aims to develop advanced platforms for testing novel insect-based foods to prevent intestinal dysbiosis and Type 2 diabetes, integrating AI for personalized nutritional interventions.
MicroBioDx: karakterisatie van microbioom-gastheer interacties
TenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren.
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sources
FIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS.